Loading
Latest filing published 23 Aug 2017 for Cardiome Pharma Corp., €15k.
David Cameron Peter Dean is a declared insider of Cardiome Pharma Corp., with filings sourced from SEDI. In total, 2 filings cover trades dated from 12 August 2016 to 23 August 2017.
Every open-market trade on record is a purchase: 2 purchases worth €33k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2017: 1 purchase and no sales on the market.
The newest entry dates from 23 August 2017: an open-market purchase of €15k, in Cardiome Pharma Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations